Adagene Inc.
ADAG- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001818838
In the last 90 days, Adagene Inc. insiders filed 4 open-market purchases and 0 sales; 35 institutions reported holding it in 13F filings for Q2 2026, worth $81.0M in total; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Adagene Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 15 | 15 | 0 |
| Shares | 8.39M | 7.53M | −860.2K (−10.3%) |
| Value | $29.7M | $15.4M | −$14.3M (−48.0%) |
New holders (3)
Institutions that held Adagene Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 21,794 | $45.0K | 0.00% |
| Virtu Financial LLC | 19,676 | $40.0K | 0.00% |
| Cannell Capital LLC | 5,285 | $11.0K | 0.00% |
Sold out (3)
Institutions that held Adagene Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Capital International Investors | 1,112,200 | $3.97M |
| Capital International Inc | 302,808 | $1.08M |
| Capital International Sarl | 28,392 | $101.0K |